Your browser doesn't support javascript.
loading
Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectiveness.
Pirillo, Chiara; Birch, Flora; Tissot, Floriane S; Anton, Sara Gonzalez; Haltalli, Myriam; Tini, Valentina; Kong, Isabella; Piot, Cécile; Partridge, Ben; Pospori, Constandina; Keeshan, Karen; Santamaria, Salvatore; Hawkins, Edwin; Falini, Brunangelo; Marra, Andrea; Duarte, Delfim; Lee, Chiu Fan; Roberts, Edward; Lo Celso, Cristina.
Afiliação
  • Pirillo C; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, United Kingdom.
  • Birch F; The Francis Crick Institute, London, United Kingdom.
  • Tissot FS; Beatson Institute for Cancer Research, Glasgow, United Kingdom.
  • Anton SG; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, United Kingdom.
  • Haltalli M; The Francis Crick Institute, London, United Kingdom.
  • Tini V; Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Kong I; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, United Kingdom.
  • Piot C; The Francis Crick Institute, London, United Kingdom.
  • Partridge B; Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Pospori C; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, United Kingdom.
  • Keeshan K; The Francis Crick Institute, London, United Kingdom.
  • Santamaria S; Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Hawkins E; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, United Kingdom.
  • Falini B; The Francis Crick Institute, London, United Kingdom.
  • Marra A; Institute of Haematology, Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Duarte D; The Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Parkville, VIC, Australia.
  • Lee CF; The Francis Crick Institute, London, United Kingdom.
  • Roberts E; Department of Bioengineering, Imperial College London, London, United Kingdom.
  • Lo Celso C; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, United Kingdom.
Blood Adv ; 6(10): 3126-3141, 2022 05 24.
Article em En | MEDLINE | ID: mdl-35157757
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article